3686
Q. Qiao et al. / Tetrahedron Letters 49 (2008) 3682–3686
irradiation (Emrys optimizer) for 60 min at 150 °C. The crude
References and notes
reaction mixture was then passed through a column of silica gel.
Thionoester 2e (1.1 g, 55%) was eluted using 0–20% ethyl acetate/
hexanes.
1. (a) Jin, Z. Nat. Prod. Rep. 2003, 20, 584–605; (b) Lewis, J. R. Nat.
Prod. Rep. 1999, 16, 389–416.
To thionoester 2e (300 mg, 1.3 mmol) in 5 mL of ether were added
10 mL of 3 N NaOH and D,L-a-phenylglycine (784 mg, 5.19 mmol).
The reaction mixture was stirred vigorously for 18 h at room
temperature. The aqueous layer was separated, acidified with 10%
HCl, and diluted with ethyl acetate. The organic layer was separated,
dried over anhydrous sodium sulfate and the solvent was removed
under reduced pressure. The oil obtained was then dissolved in acetic
anhydride (5 mL) and heated at 100 °C for 1 h. The reaction mixture
was evaporated to afford 310 mg (64%) of the desired thiazole 8: 1H
NMR (400 MHz, CDCl3): d 2.45 (s, 3H, CH3), 7.32 (t, J = 7.9 Hz,
1H, aromatic), 7.38 (m, 1H, aromatic), 7.49 (m, 2H, aromatic), 7.55
(ddd, J = 7.9 Hz, J = 1.8 Hz, J = 1.0 Hz, 1H, aromatic), 7.87 (ddd,
J = 7.9 Hz, J = 1.8 Hz, J = 1.0 Hz, 1H, aromatic), 8.04 (m, 2H,
aromatic), 8.18 (t, J = 1.8 Hz, 1H, aromatic). HRMS (ES+) m/z calcd
for C17H12NO2SBr [M+H]+ 373.9845, obsd 373.9844.
2. Sperry, J. B.; Wright, D. L. Curr. Opin. Drug. Discovery Dev. 2005, 8,
723–740.
3. (a) Zhao, H. Drug Discovery Today 2007, 12, 149–155; (b) Schneider,
G.; Schneider, P.; Renner, S. QSAR Comb. Sci. 2006, 25, 1162–1171;
(c) Bo¨hm, H.-J.; Flohr, A.; Stahl, M. Drug Discovery Today: Technol.
2004, 1, 217–224; (d) Wermuth, C. G. In The Practice of Medicinal
Chemistry, 2nd ed.; Academic Press: London, 2003; pp 193–196.
4. (a) Biron, E.; Chatterjee, J.; Kessler, H. Org. Lett. 2006, 8, 2417–2420;
(b) Deng, S.; Taunton, J. Org. Lett. 2005, 7, 299–301.
5. Dolle, R. E.; Le Bourdonnec, B.; Morales, G. A.; Moriarty, K. J.;
Salvino, J. M. J. Comb. Chem. 2006, 8, 597–635.
6. (a) Aguilar, E.; Meyers, A. I. Tetrahedron Lett. 1994, 35, 2473–2476;
(b) Wipf, P.; Venkatraman, S. J. Org. Chem. 1996, 61, 8004–8005; (c)
Qiao, Q.; So, S.-S.; Goodnow, R. A., Jr. Org. Lett. 2001, 3, 3655–
3658; (d) Hodgetts, K. J.; Kershaw, M. T. Org. Lett. 2002, 4, 1363–
1365; (e) Marcantonio, K. M.; Frey, F. L.; Murry, J. A.; Chen, C.-Y.
Tetrahedron Lett. 2002, 43, 8845–8848; (f) Ochiai, M.; Nishi, Y.;
Hashimoto, S.; Tsuchimoto, Y.; Chen, D.-W. J. Org. Chem. 2003, 68,
7887–7888; (g) Boy, K. M.; Guernon, J. M. Tetrahedron Lett. 2005,
46, 2251–2252; (h) Thompson, M. J.; Heal, W.; Chen, B. Tetrahedron
Lett. 2006, 47, 2361–2364.
7. (a) Barrett, G. C.; Khokhar, A. R. J. Chem. Soc. 1969, 1117–1119; (b)
Sammour, A.; Selim, M.; Fahmy, A. F.; Nada, A. A.; Abd
Elmawgoud, I. A. Egypt. J. Chem. 1976, 19, 801–809; (c) Sammour,
A.; Abdallah, M. M.; Essawy, A.; Elmobayed, M. Egypt. J. Chem.
1976, 19, 911–926; (d) El-Kadi, M.; El-Hashash, M. A.; Sayed, M. A.
Rev. Roum. Chim. 1981, 26, 1161–1167.
8. Kappe, C. O.; Dallinger, D. Nat. Rev. Drug Disc. 2006, 5, 51–63.
9. Polshettiwar, V.; Nivsarkar, M.; Paradashani, D.; Kaushik, M. P. J.
Chem. Res. 2004, 474–476.
10. Varma, R. S.; Kumar, D. Org. Lett. 1999, 1, 697–700.
11. Jesberger, M.; Davis, T. P.; Barner, L. Synthesis 2003, 1929–1958.
12. (a) Curphey, T. J. Tetrahedron Lett. 2002, 43, 371–373; (b) Curphey,
T. J. J. Org. Chem. 2002, 67, 6461–6473.
15. Representative procedure for the synthesis of thiazol-5-ones and 2,4,5-
trisubstituted thiazoles: To thiazole 4 (100 mg, 0.34 mmol), K2CO3
(234 mg, 1.69 mmol) in 2 mL of DMF was added dimethyl sulfate
(64 lL, 0.68 mmol). The reaction mixture was stirred and heated at
50 °C for 1 h, then cooled down. The reaction mixture was diluted
with ethyl acetate and washed with water and brine. The combined
organic phases were dried over anhydrous sodium sulfate and the
solvent was removed under reduced pressure. The crude material was
then purified by column chromatography using 10% ethyl acetate/
hexanes as eluent system to afford 65 mg (70%) of 2,4,5-trisubstituted
thiazole 26: 1H NMR (400 MHz, CDCl3): d 4.08 (s, 3H, CH3), 7.31
(m, 1H, aromatic), 7.37–7.48 (m, 5H, aromatic), 7.93 (m, 2H,
aromatic), 8.13 (m, 2H, aromatic); 13C (100 MHz, CDCl3): d 63.9,
125.5, 126.8, 126.9, 128.2, 128.7, 129.2, 133.8, 134.1, 135.6, 153.0,
157.4. HRMS (ES+) m/z calcd for C16H13NOS [M+H]+ 268.0791,
obsd 268.0790.
16. For 25: 1H NMR (400 MHz, CDCl3): d 3.10 (m, 2H, CH2), 5.11 (m,
1H, vinylic), 5.19 (m, 1H, vinylic), 5.71 (m, 1H, vinylic), 7.32–7.44 (m,
4H, aromatic), 7.55 (m, 2H, aromatic), 7.71 (ddd, J = 8.0 Hz, J = 2.0
Hz, J = 1.1 Hz, 1 H, aromatic), 7.82 (ddd, J = 7.8 Hz, J = 1.7 Hz,
J = 1.1 Hz, 1 H, aromatic), 8.1 (dd, J = 2.0 Hz, J = 1.7 Hz, 1H,
aromatic); 13C (100 MHz, CDCl3): 44.5, 91.3, 120.2, 123.1, 125.6,
127.1, 128.4, 128.6, 130.3, 130.6, 130.9, 135.0, 135.1, 137.4, 162.2,
207.9. HRMS (ES+) m/z calcd for C18H14NOSBr [M+H]+ 372.0052,
obsd 372.0052.
13. (a) Katada, T.; Kato, S.; Mizuta, M. Chem. Lett. 1975, 1037–1040; (b)
Latif, K. A.; Ali, M. Y. Tetrahedron 1970, 26, 4247–4249; (c) Voss, J.;
Wollny, B. Synthesis 1989, 684–685.
14. Representative procedure for the synthesis of 2,4-disubstituted-5-acet-
oxythiazoles:
A mixture of methyl 3-bromo-benzoate (2.0 g,
9.3 mmol), P4S10 (1.03 g, 2.32 mmol), HMDO (3.2 mL, 14.9 mmol)
was sealed in a tube. The sealed vial was heated by microwave